CY1108991T1 - Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18 - Google Patents

Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18

Info

Publication number
CY1108991T1
CY1108991T1 CY20091100489T CY091100489T CY1108991T1 CY 1108991 T1 CY1108991 T1 CY 1108991T1 CY 20091100489 T CY20091100489 T CY 20091100489T CY 091100489 T CY091100489 T CY 091100489T CY 1108991 T1 CY1108991 T1 CY 1108991T1
Authority
CY
Cyprus
Prior art keywords
human administration
healing method
injury healing
human
injury
Prior art date
Application number
CY20091100489T
Other languages
English (en)
Inventor
Judithann Lee
Kimberly A Dede
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of CY1108991T1 publication Critical patent/CY1108991T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται γενικώς στη χρήση ανθρώπινης IL-18, επίσης γνωστής ως παράγοντα επαγωγής ιντερφερόνης-γ (IGIF), στη θεραπεία τραυμάτων του δέρματος, χειρουργικών τραυμάτων, ελκών ποδιού, διαβητικών ελκών, γαστρεντερικής βλεννογονίτιδας, στοματικής βλεννογονίτιδας, και τραυματισμού του πνεύμονα.
CY20091100489T 2004-08-20 2009-05-07 Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18 CY1108991T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60301204P 2004-08-20 2004-08-20
EP05789011A EP1793859B1 (en) 2004-08-20 2005-08-18 Treatment of oral and intestinal mucositis by administering human il-18

Publications (1)

Publication Number Publication Date
CY1108991T1 true CY1108991T1 (el) 2014-07-02

Family

ID=35968167

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100489T CY1108991T1 (el) 2004-08-20 2009-05-07 Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18

Country Status (24)

Country Link
US (1) US7595039B2 (el)
EP (2) EP2161032B1 (el)
JP (1) JP4912306B2 (el)
KR (1) KR20070050924A (el)
CN (1) CN101039696B (el)
AT (2) ATE426410T1 (el)
AU (1) AU2005277404A1 (el)
BR (1) BRPI0514445A (el)
CA (1) CA2577777A1 (el)
CY (1) CY1108991T1 (el)
DE (1) DE602005013542D1 (el)
DK (1) DK1793859T3 (el)
ES (2) ES2372728T3 (el)
HK (1) HK1109054A1 (el)
IL (1) IL181286A0 (el)
MX (1) MX2007002134A (el)
NO (1) NO20071238L (el)
NZ (1) NZ552837A (el)
PL (1) PL1793859T3 (el)
PT (1) PT1793859E (el)
RU (1) RU2387455C2 (el)
SI (1) SI1793859T1 (el)
WO (1) WO2006023623A2 (el)
ZA (1) ZA200700524B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ520392A (en) * 2000-02-10 2005-04-29 Abbott Lab Antibodies that bind human interleukin-18 and methods of making and using
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
JP6005736B2 (ja) 2011-06-13 2016-10-12 ニューメディシンズ，インコーポレーテッド Ｉｌ−１２を用いる皮膚損傷の軽減
EP3041864B1 (en) * 2013-09-05 2021-07-21 AB2 Bio SA Il-18 binding protein (il-18bp) in inflammatory diseases
AU2016227644B2 (en) 2015-03-05 2022-06-16 Ab2 Bio Sa IL-18 Binding Protein (IL-18BP) and antibodies in inflammatory diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0692536B1 (en) 1994-07-14 2000-11-22 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo IFN-Y production inducing protein and monoclonal antibody of the same
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
US5680795A (en) 1995-07-05 1997-10-28 Norco Inc. Mechanical drive assembly incorporating counter-spring biassed radially-adjustable rollers
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
NZ523123A (en) * 2000-06-02 2005-12-23 Smithkline Beecham Corp Methods of treating viral diseases with IL-18 and IL-18 combinations with anti-viral drugs
CZ20024085A3 (cs) * 2000-06-15 2003-05-14 Smithkline Beecham Corporation Způsob přípravy fyziologicky aktivního IL-18 polypeptidu
US7098373B2 (en) * 2001-07-12 2006-08-29 Hitoshi Mizutani IL-18 transgenic animal
WO2004024180A1 (en) * 2002-09-16 2004-03-25 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
AU2003295331A1 (en) * 2002-09-19 2004-04-23 Centocor, Inc. Method of inducing maturation of dendritic cells and uses therefor
US20050075277A1 (en) * 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
EP1793859A4 (en) 2008-02-13
ES2322605T3 (es) 2009-06-23
ATE526057T1 (de) 2011-10-15
CN101039696A (zh) 2007-09-19
RU2387455C2 (ru) 2010-04-27
DE602005013542D1 (de) 2009-05-07
NZ552837A (en) 2009-09-25
PT1793859E (pt) 2009-06-04
NO20071238L (no) 2007-05-14
EP2161032B1 (en) 2011-09-28
DK1793859T3 (da) 2009-06-22
US20060039892A1 (en) 2006-02-23
EP1793859A2 (en) 2007-06-13
JP4912306B2 (ja) 2012-04-11
AU2005277404A1 (en) 2006-03-02
MX2007002134A (es) 2007-09-14
EP2161032A2 (en) 2010-03-10
ZA200700524B (en) 2008-05-28
WO2006023623A2 (en) 2006-03-02
RU2007110166A (ru) 2008-09-27
CN101039696B (zh) 2011-08-17
EP2161032A3 (en) 2010-07-28
PL1793859T3 (pl) 2009-08-31
WO2006023623A3 (en) 2006-08-24
ATE426410T1 (de) 2009-04-15
SI1793859T1 (sl) 2009-06-30
EP1793859B1 (en) 2009-03-25
US7595039B2 (en) 2009-09-29
IL181286A0 (en) 2007-07-04
ES2372728T3 (es) 2012-01-25
KR20070050924A (ko) 2007-05-16
CA2577777A1 (en) 2006-03-02
JP2008510709A (ja) 2008-04-10
HK1109054A1 (en) 2008-05-30
BRPI0514445A (pt) 2008-06-10

Similar Documents

Publication Publication Date Title
CY1111797T1 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
CY1117770T1 (el) Διαδερμικο θεραπευτικο συστημα για χορηγηση της δραστικης ουσιας βουπρενορφινη
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
PA8453501A1 (es) Derivados dipeptidicos
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
CY1108991T1 (el) Μεθοδος επουλωσης τραυματων με τη χορηγηση ανθρωπινης il-18
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
CR11120A (es) Adaptador para un introductor
CY1120701T1 (el) Υποκατεστημενες πιπεριδινυλο-τετραϋδροκινολινες και η χρηση τους ως ανταγωνιστες αλφα-2c αδρενεργικου υποδοχεα
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
CY1115961T1 (el) Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate)
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
CY1109733T1 (el) Χρησιμοποιηση πολυαιθυλενο γλυκολης για τη θεραπεια παθησεων ασθενειων και τραυματων, που εχουν σχεση με φλεγμονη
EA200602002A1 (ru) Применение спинозинов для заживления ран
Li et al. Burn wound mucormycosis: a case report
ATE468133T1 (de) Verwendung von g-csf als zusätzliche behandlung in die wiederherstellung von bindegewebe
Miller et al. Burns to the Feet
Bundele et al. Wound coverage in diabetic foot
DE50310383D1 (de) Humanes chondroosteomodulin (tig2), herstellung und verwendung zur behandlung oder diagnose von knochen- und knorpelerkrankungen, fettsucht sowie entzündlichen erkrankungen und hauterkrankungen
Rampal et al. Single incision fasciotomy to treat compartment syndrome in the diabetic foot: A case report
CY1109052T1 (el) Χρηση μιας φαρμακευτικης συνθεσης που περιεχει επιδερμικο παραγοντα αναπτυξης (egf) για αποτροπη ακρωτηριασμου διαβητικου ποδος
MX2007007304A (es) Aceite regenerador celular.
NO20064828L (no) Ny anvendelse av peptidforbindelser for behandling av smerte i smertefull diabetisk neuropati.